Cerebral stroke injury: The role of cytokines and brain inflammation

Journal of Basic and Clinical Physiology and Pharmacology

Volumn 25, Issue 2, 2014, Pages 131-137

  Siniscalchi, Antonio ^b   Gallelli, Luca ^a   Malferrari, Giovanni ^c   Pirritano, Domenico ^d   Serra, Raffaele ^e   Santangelo, Ermenegildo ^e   De Sarro, Giovambattista ^e  

^a Mater Domini University Hospital   (Italy)

^b ANNUNZIATA HOSPITAL   (Italy)

^c S MARIA NUOVA HOSPITAL   (Italy)

^d SAN GIOVANNI DI DIO HOSPITAL   (Italy)

^e UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

cerebral ischemia; immune system; inflammation

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GELATINASE A; GELATINASE B; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 20; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; SELECTIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANTIINFLAMMATORY ACTIVITY; BRAIN ISCHEMIA; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOKINE RESPONSE; DISEASE ASSOCIATION; ENCEPHALITIS; EXPERIMENTAL STROKE; HUMAN; INFLAMMATION; NONHUMAN; PROGNOSIS; PROTEIN BLOOD LEVEL; REVIEW; STROKE PATIENT; TISSUE REPAIR; ANIMAL; BLOOD; COMPLICATION; IMMUNOLOGY; METABOLISM; OXIDATIVE STRESS; STROKE;

ANIMALS; BRAIN ISCHEMIA; CYTOKINES; ENCEPHALITIS; HUMANS; OXIDATIVE STRESS; STROKE;

EID: 84899870738     PISSN: 07926855     EISSN: 21910286     Source Type: Journal    
DOI: 10.1515/jbcpp-2013-0121     Document Type: Review

References (62)

1. Lo EH, Dalkara T, Moskowitz MA. Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci 2003;4: 399-415.
2. Norrving B, Kissela B. The global burden of stroke and need for a continuum of care. Neurology 2013;80:S5-12.
3. Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet 2008;371:1612-23.
4. Lakhan SE, Kirchgessner A, Hofer M. Inflammatory mechanisms in ischemic stroke: therapeutic approaches. J Transl Med 2009;7:97.
5. Muir KW, Tyrrell P, Sattar N, Warburton E. Inflammation and ischaemic stroke. Curr Opin Neurol 2007;20:334-42.
6. Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 1999;22:391-7.
7. Chamorro A, Hallenbeck J. The harms and benefits of inflammatory and immune responses in vascular disease. Stroke 2006;37:291-3.
8. Iadecola C, Anrather J. The immunology of stroke: from mechanisms to translation. Nat Med 2011;17:796-808.
9. Moskowitz MA, Lo EH, Iadecola C. The science of stroke: mechanisms in search of treatments. Neuron 2010;67:181-98.
10. Allan SM, Rothwell NJ. Cytokines and acute neurodegeneration. Nat Rev Neurosci 2001;2:734-44.
11. Urra X, Cerveraa A, Villamor N, Planas AM, Chamorro A. Harms and benefits of lymphocyte subpopulations in patients with acute stroke. Neuroscience 2009;158:1174-83.
12. Steinman L. A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell-mediated tissue damage. Nat Med 2007;13:139-45.
13. Gallelli L, Busceti MT, Vatrella A, Maselli R, Pelaia G. Update on anticytokine treatment for asthma. Biomed Res Int 2013;2013:104315.
14. Rubio-Perez JM, Morillas-Ruiz JM. A review: inflammatory process in Alzheimer's disease, role of cytokines. Sci World J 2012;2012:756357.
15. Rock KL, Latz E, Ontiveros F, Kono H. The sterile inflammatory response. Annu Rev Immunol 2010;28:321-42.
16. Zhu Y, Yang GY, Ahlemeyer B, Pang L, Che XM, Culmsee C, et al. Transforming growth factor-1 increases bad phosphorylation and protects neurons against damage. J Neurosci 2002;22:3898-909.
17. Spera PA, Ellison JA, Feuerstein GZ, Barone FC. IL-10 reduces rat brain injury following focal stroke. Neurosci Lett 1998;251: 189-92.
18. Banwell V, Sena ES, Macleod MR. Systematic review and stratified meta-analysis of the efficacy of interleukin-1 receptor antagonist in animal models of stroke. J Stroke Cerebrovasc Dis 2009;18:269-76.
19. Elkind MS. Impact of innate inflammation in population studies. Ann NY Acad Sci 2010;1207:97-106.
20. Offner H, Subramanian S, Parker SM, Afentoulis ME, Vandenbark AA, Hurn PD. Experimental stroke induces massive, rapid activation of the peripheral immune system. J Cereb Blood Flow Metab 2006;26:654-65.
21. Lambertsen KL, Biber K, Finsen B. Inflammatory cytokines in experimental and human stroke. J Cereb Blood Flow Metab 2012;32:1677-98.
22. Murray KN, Buggey HF, Denes A, Allan SM. Systemic immune activation shapes stroke outcome. Mol Cell Neurosci 2013;53:14-25.
23. Mazzotta G, Sarchielli P, Caso V, Paciaroni M, Floridi A, Gallai V. Different cytokine levels in thrombolysis patients as predictors for clinical outcome. Eur J Neurol 2004;11:377-81.
24. Yan J, Greer JM, McCombe PA. Prolonged elevation of cytokine levels after human acute ischaemic stroke with evidence of individual variability. J Neuroimmunol 2012;246:78-84.
25. Zeng L, Wang Y, Liu J, Wang L, Weng S, Chen K, et al. Pro-inflammatory cytokine network in peripheral inflammation response to cerebral ischemia. Neurosci Lett 2013;548:4-9.
26. Tobinick E, Kim NM, Reyzin G, Rodriguez-Romanacce H, DePuy V. Selective TNF inhibition for chronic stroke and traumatic brain injury: an observational study involving 629 consecutive patients treated with perispinal etanercept. CNS Drugs 2012;26:1051-70.
27. Caso JR, Moro MA, Lorenzo P, Lizasoain I, Leza JC. Involvement of IL-1 in acute stress-induced worsening of cerebral ischaemia in rats. Eur Neuropsychopharm 2007;17:600-7.
28. Boutin H, LeFeuvre RA, Horai R, Asano M, Iwakura Y, Rothwell NJ. Role of IL-1 and IL-1 in ischemic brain damage. J Neurosci 2001;21:5528-34.
29. Deroide N, Li X, Lerouet D, Van Vre E, Baker L, Harrison J, et al. MFGE8 inhibits inflammasome-induced IL-1 production and limits postischemic cerebral injury. J Clin Invest 2013;123: 1176-81.
30. Clark WM, Rinker LG, Lessov NS, Hazel K, Eckenstein F. Time course of IL-6 expression in experimental CNS ischemia. Neurol Res 1999;21:287-92.
31. Acalovschi D, Wiest T, Hartmann M, Farahmi M, Mansmann U, Auffarth GU, et al. Multiple levels of regulation of the interleukin-6 system in stroke. Stroke 2003;34:1864-9.
32. Vila N, Castillo J, Davalos A, Chamorro A. Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke 2000;31:2325-9.
33. Clark WM, Rinker LG, Lessov NS, Hazel K, Hill JK, Stenzel-Poore M, et al. Lack of interleukin-6 expression is not protective against focal central nervous system ischemia. Stroke 2000;31:1715-20.
34. Chen WY, Chang MS. IL-20 is regulated by hypoxia-inducible factor and up-regulated after experimental ischemic stroke. J Immunol 2009;182:5003-12.
35. Smith CJ, Emsley HC, Udeh CT, Vail A, Hoadley ME, Rothwell NJ, et al. Interleukin-1 receptor antagonist reverses strokeassociated peripheral immune suppression. Cytokine 2012;58:384-9.
36. Gueorguieva I, Clark SR, McMahon CJ, Scarth S, Rothwell NJ, Tyrell PJ, et al. Pharmacokinetic modelling of interleukin-1 receptor antagonist in plasma and cerebrospinal fluid of patients following subarachnoid haemorrhage. Br J Clin Pharmacol 2008;65:317-25.
37. Bodhankar S, Chen Y, Vandenbark AA, Murphy SJ, Offner H. IL-10-producing B-cells limit CNS inflammation and infarct volume in experimental stroke. Metab Brain Dis 2013;28:375-86.
38. Tarkowski E, Rosengren L, Blomstrand C, Wikkelso C, Jensen C, Ekholm S, et al. Intrathecal release of pro-and anti-inflammatory cytokines during stroke. Clin Exp Immunol 1997;110:492-9.
39. da Cunha AA, Ferreira AG, Loureiro SO, da Cunha MJ, Schmitz F, Netto CA, et al. Chronic hyperhomocysteinemia increases inflammatory markers in hippocampus and serum of rats. Neurochem Res 2012;37:1660-9.
40. Siniscalchi A. Hyperhomocysteinemia in neurologic diseases. Recenti Prog Med 2004;95:371-5; quiz 402.
41. Siniscalchi A, De Sarro G, Loizzo S, Gallelli L. High plasma homocysteine and low serum folate levels induced by antiepileptic drugs in Down Syndrome. J Dev Disabil 2012;18:70-6.
42. Siniscalchi A, Gallelli L, Mercuri NB, Ibbadu GF, De Sarro G. Role of lifestyle factors on plasma homocysteine levels in Parkison's disease patients treated with levodopa. Nutr Neurosci 2006;9:11-6.
43. Siniscalchi A, Mancuso F, Gallelli L, Ibbadu GF, Mercuri NB, De Sarro G. Increase in plasma homocysteine levels induced by drug treatments in neurologic patients. Pharmacol Res 2005;52:367-75.
44. Sprague AH, Khalil RA. Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem Pharmacol 2009;78:539-52.
45. Iversen PO, Nicolaysen A, Kvernebo K, Benestad HB, Nicolaysen G. Human cytokines modulate arterial vascular tone via endothelial receptors. Pflugers Arch 1999;439:93-100.
46. Vila E, Salaices M. Cytokines and vascular reactivity in resistance arteries. Am J Physiol Heart Circ Physiol 2005;288:H1016-21.
47. Hallenbeck JM. The many faces of tumor necrosis factor in stroke. Nat Med 2002;8:1363-8.
48. Song W, Huo T, Guo F, Wang H, Wei H, Yang Q, et al. Globular adiponectin elicits neuroprotection by inhibiting NADPH oxidase-mediated oxidative damage in ischemic stroke. Neuroscience 2013;248C:136-44.
49. Pham LD, Hayakawa K, Seo JH, Nguyen MN, Som AT, Lee BJ, et al. Crosstalk between oligodendrocytes and cerebral endothelium contributes to vascular remodeling after white matter injury. Glia 2012;60:875-81.
50. de Franciscis S, Mastroroberto P, Gallelli L, Buffone G, Montemurro R, Serra R. Increased plasma levels of metalloproteinase-9 and neutrophil gelatinase-associated lipocalin in a rare case of multiple artery aneurysm. Ann Vasc Surg 2013;27:1185 e5-7.
51. de Franciscis S, Gallelli L, Battaglia L, Molinari V, Montemurro R, Stillitano DM, et al. Cilostazol prevents foot ulcers in diabetic patients with peripheral vascular disease. Int Wound J 2013; Epub ahead of print 15 May 2013. DOI: 10.1111/iwj.12085.
52. Serra R, Buffone G, Falcone D, Molinari V, Scaramuzzino M, Gallelli L, et al. Chronic venous leg ulcers are associated with high levels of metalloproteinases-9 and neutrophil gelatinaseassociated lipocalin. Wound Repair Regen 2013;21:395-401.
53. Serra R, Gallelli L, Buffone G, Molinari V, Stillitano DM, Palmieri C, et al. Doxycycline speeds up healing of chronic venous ulcers. Int Wound J 2013; Epub ahead of print 5 Apr 2013. DOI: 10.1111/iwj.12077.
54. Liu H, Wei X, Chen L, Liu X, Li S, Zhang X. Tetramethylpyrazine analogue CXC195 protects against cerebral ischemia/reperfusion injury in the rat by an antioxidant action via inhibition of NADPH oxidase and iNOS expression. Pharmacology 2013;92:198-206.
55. Offner H, Vandenbark AA, Hurn PD. Effect of experimental stroke on peripheral immunity: CNS ischemia induces profound immunosuppression. Neuroscience 2009;158:1098-111.
56. Chapman KZ, Dale VQ, Denes A, Bennett G, Rothwell NJ, Allan SM, et al. A rapid and transient peripheral inflammatory response precedes brain inflammation after experimental stroke. J Cereb Blood Flow Metab 2009;29:1764-8.
57. Chang L, Chen Y, Li J, Liu Z, Wang Z, Chen J, et al. Cocaine-and amphetamine-regulated transcript modulates peripheral immunity and protects against brain injury in experimental stroke. Brain Behav Immun 2011;25:260-9.
58. Kamel H, Iadecola C. Brain-immune interactions and ischemic stroke: clinical implications. Arch Neurol 2012;69:576-81.
59. Sanchez-Mendoza E, Bellver V, Merino JJ, Gonzalez M, Martinez-Murillo R, Oset-Gasque MJ. Review: could neurotransmitters influence neurogenesis and neurorepair after stroke? Neuropathol Appl Neurobiol 2013; Epub ahead of print 14 Aug 2013. DOI: 10.1111/nan.12082.
60. Albers GW, Goldstein LB, Hess DC, Wechsler LR, Furie KL, Gorelick PB, et al. Stroke Treatment Academic Industry Roundtable (STAIR) recommendations for maximizing the use of intravenous thrombolytics and expanding treatment options with intra-arterial and neuroprotective therapies. Stroke 2011;42:2645-50.
61. Tiebosch IA, Crielaard BJ, Bouts MJ, Zwartbol R, Salas-Perdomo A, Lammers T, et al. Combined treatment with recombinant tissue plasminogen activator and dexamethasone phosphatecontaining liposomes improves neurological outcome and restricts lesion progression after embolic stroke in rats. J Neurochem 2012;123:65-74.
62. Rodriguez-Yanez M, Castellanos M, Sobrino T, Brea D, Ramos-Cabrer P, Pedraza S, et al. Interleukin-10 facilitates the selection of patients for systemic thrombolysis. BMC Neurol 2013;13:62.